Table 1.
NIAID Support for Ebola Research FY2004-13 (in $Millions)
Fiscal Year | Basic | Vaccine | Therapeutics | Diagnostic | Total |
---|---|---|---|---|---|
2004 | 6.06 | 15.15 | 1.88 | 17.03 | |
2005 | 8.48 | 16.04 | 4.94 | 20.97 | |
2006 | 7.83 | 31.70 | 19.48 | 51.18 | |
2007 | 6.43 | 31.18 | 3.09 | 34.27 | |
2008 | 7.93 | 11.61 | 30.59 | 0.15 | 42.34 |
2009 | 15.48 | 20.84 | 6.22 | 0.12 | 27.18 |
2010 | 11.69 | 37.16 | 8.85 | 0.91 | 46.93 |
2011 | 13.80 | 17.57 | 8.67 | 2.84 | 29.08 |
2012 | 13.56 | 22.51 | 9.52 | 2.92 | 34.95 |
2013 | 131.37 | 17.19 | 10.31 | 1.86 | 29.35 |
Total | 222.63 | 220.94 | 103.55 | 8.79 | 333.29 |
Note. Adapted from personal communication with NIAID. Funding amounts were provided by NIAID in September 2014. Amounts here exclude funding as part of the American Recovery and Reinvestment Act (ARRA).